Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2DR REDDYS

02 2ACCORD HLTHCARE INC

03 2APOTEX

04 2BOEHRINGER INGELHEIM

05 2CIPLA

06 2DEXCEL

07 1EUGIA PHARMA SPECLTS

08 1GLENMARK PHARMS LTD

09 2HUMANWELL PURACAP PHARMACEUTICALS (WUHAN) CO., LTD

10 1QILU PHARMACEUTICAL CO., LTD.

11 2SANDOZ

12 2TEVA PHARMACEUTICALS DEVELOPMENT INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

RLD : No

TE Code : AB

NINTEDANIB ESYLATE

Brand Name : NINTEDANIB ESYLATE

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 100MG BASE

Approval Date : 2026-04-02

Application Number : 219283

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Dr Reddy Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

RLD : No

TE Code : AB

NINTEDANIB ESYLATE

Brand Name : NINTEDANIB ESYLATE

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 150MG BASE

Approval Date : 2026-04-02

Application Number : 219283

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Dr Reddy Company Banner

03

Bioprocess International Europe
Not Confirmed
arrow
arrow
Bioprocess International Europe
Not Confirmed

NINTEDANIB

Brand Name : NINTEDANIB

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 100MG BASE

Approval Date :

Application Number : 212732

RX/OTC/DISCN :

RLD :

TE Code :

blank

04

Bioprocess International Europe
Not Confirmed
arrow
arrow
Bioprocess International Europe
Not Confirmed

NINTEDANIB

Brand Name : NINTEDANIB

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 150MG BASE

Approval Date :

Application Number : 212732

RX/OTC/DISCN :

RLD :

TE Code :

blank

05

Bioprocess International Europe
Not Confirmed
arrow
arrow
Bioprocess International Europe
Not Confirmed

NINTEDANIB

Brand Name : NINTEDANIB

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 150MG BASE

Approval Date :

Application Number : 215123

RX/OTC/DISCN :

RLD :

TE Code :

blank

06

Bioprocess International Europe
Not Confirmed
arrow
arrow
Bioprocess International Europe
Not Confirmed

NINTEDANIB ESYLATE

Brand Name : OFEV

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 100MG BASE

Approval Date : 2014-10-15

Application Number : 205832

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

blank

07

Bioprocess International Europe
Not Confirmed
arrow
arrow
Bioprocess International Europe
Not Confirmed

NINTEDANIB ESYLATE

Brand Name : OFEV

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 150MG BASE

Approval Date : 2014-10-15

Application Number : 205832

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

blank

08

Bioprocess International Europe
Not Confirmed
arrow
arrow
Bioprocess International Europe
Not Confirmed

NINTEDANIB ESYLATE

Brand Name : NINTEDANIB ESYLATE

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 100MG BASE

Approval Date : 2026-04-02

Application Number : 212609

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

09

Bioprocess International Europe
Not Confirmed
arrow
arrow
Bioprocess International Europe
Not Confirmed

NINTEDANIB ESYLATE

Brand Name : NINTEDANIB ESYLATE

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 150MG BASE

Approval Date : 2026-04-02

Application Number : 212609

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

10

Bioprocess International Europe
Not Confirmed
arrow
arrow
Bioprocess International Europe
Not Confirmed

NINTEDANIB ESYLATE

Brand Name : NINTEDANIB

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 150MG BASE

Approval Date :

Application Number : 212555

RX/OTC/DISCN :

RLD :

TE Code :

blank